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ABSTRACT
Objective To test the effectiveness of large scale distribution
of longlasting nets treated with insecticide in reducing the
incidence of visceral leishmaniasis in India and Nepal.
Design Paired cluster randomised controlled trial
designed to detect a 50% reduction in incidence of
Leishmania donovani infection.
Setting Villages in Muzaffarpur district in India and
Saptari, Sunsari, and Morang districts in Nepal.
Participants 13 intervention and 13 control clusters.
12691 people were included in the analysis of the main
outcome (infection), and 19810 were enrolled for the
secondary (disease) end point.
Intervention Longlasting insecticidal nets (treated with
deltamethrin)were distributed in the intervention clusters
in December 2006.
Main outcome measures Infection was determined by
direct agglutination test at 12 and 24 months after the
intervention in those who had negative results (titre
<1:1600) at baseline. The effect estimate was computed
as the geometric mean of the risk ratios for
seroconversion for each cluster pair (net/no net), with its
95% confidence interval. Formal tests of effect of no
intervention were obtained with a paired t test.
Results There was no significant difference in the risk of
seroconversion over 24 months in intervention (5.4%;
347/6372) compared with control (5.5%; 345/6319
people) clusters (risk ratio 0.90, 95% confidence interval
0.49 to 1.65) nor in the risk of clinical visceral
leishmaniasis (0.99, 0.46 to 1.40). Adjustment for
covariates did not alter these conclusions.
Conclusions There is no evidence that large scale
distribution of longlasting insecticidal nets provides
additional protection against visceral leishmaniasis
compared with existing control practice in the Indian
subcontinent. The observed effect was small and not
significant, though the confidence intervals did not
exclude a 50% change in either direction.
Trial registration Clinical Trials NCT 2005-015374.
INTRODUCTION
Visceral leishmaniasis is a neglected infectious disease1
caused by intramacrophage protozoa of theLeishmania
donovani complex transmitted by phlebotomine sand-
flies.Only a fraction of people infected develop clinical
visceral leishmaniasis, characterised by febrile spleno-
megaly, pancytopenia, and progressive wasting, which
can be fatal if left untreated. Visceral leishmaniasis,
also known as kala-azar, affects an estimated 500 000
people annually,mostly inAsia andEastAfrica,2 and is
especially prevalent in poor communities.3 In India,
Nepal, and Bangladesh, it is transmitted between peo-
ple by Phlebotomus argentipes,4 a peridomestic species of
sandfly whose indoor biting rhythm peaks at night.5
The current vector control strategy is based on indoor
residual spraying with dicophane (DDT) or pyre-
throids and has been criticised for being costly, not
easily accepted, and not sustainable.6 7 Bed nets treated
with insecticide, specifically longlasting nets treated
with insecticide, have been proposed as an alternative
to indoor residual spraying.6 Treatednets proved effec-
tive in control of malaria8 and cutaneous leishmaniasis
in Iran andSyria.6Current evidence on effectiveness of
treated nets for prevention of visceral leishmaniasis is
limited to entomological data69-11 and an observational
study in Sudan,12 but the latter cannot be extrapolated
to the Indian subcontinent because the vector is differ-
ent. Longlasting insecticidal nets have potential for
control of visceral leishmaniasis in this region given
the behaviour of P argentipes,5 the high acceptability
of bed nets,13 the fact that untreated nets seem to pro-
vide some degree of personal protection,14-16 and that
village-widedistributionof longlasting insecticidal nets
reduced the indoor density ofP argentipes.10 11 In 2005, a
community intervention trial was set up in India and
Nepal to test the effectiveness of comprehensive cover-
age with longlasting insecticidal nets on the incidence
of L donovani infection in the current context, where
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indoor residual spraying and untreated nets are irregu-
larly used.
METHODS
Study design
We used a pair matched cluster randomised trial
design as visceral leishmaniasis has a patchy spatial dis-
tribution and clusters strongly within villages at ham-
let/neighbourhood (tola) and household level.
Hamlets were chosen as the unit of analysis as they
would be the unit of intervention for a control pro-
gramme.Clusterswere paired on the basis of incidence
of visceral leishmaniasis between 2003 and 2005.
Study population
The trial was conducted in Muzaffarpur district in
India and Saptari, Sunsari, and Morang districts in
Nepal. The clusters—either a complete hamlet or a
ward (that is, the smallest administrative subdivision)
—were selected in a two step procedure. In February
2006 we identified 34 clusters with a high number of
reported cases of visceral leishmaniasis (22 in India, 12
in Nepal) and conducted a house to house survey to
retrospectively estimate the incidence of visceral leish-
maniasis between 2003 and 2005. In May 2006, we
selected and included in the trial 26 high incidence
clusters out of these 34 (16 in India, 10 in Nepal)
based on the following criteria: at least one case of visc-
eral leishmaniasis in 2003, 2004, and 2005, indicating
continuous L donovani transmission; a minimum 0.8%
average annual incidence rate of visceral leishmaniasis
from 2003 to 2005; a population ranging from 350 to
1500people; and aminimumdistance of 1 kmbetween
clusters. A census was conducted in July-August 2006
registering individual and household demographic
information. All data were entered into a geo-refer-
enced database. All individuals living for at least six
months a year in the clusters were eligible, but blood
sampling was restricted to individuals aged over
2 years.
Intervention
Between November and December 2006, longlasting
insecticidal nets (PermaNet 2.0, Vestergaard-Frand-
sen, Denmark; 75 denier, 25 holes/cm2, with deltame-
thrin (55 mg/m2) coated fibres) were distributed in the
intervention clusters. Enough nets were provided to
protect all household members, taking into account
the number of people (median five people/household),
their age, sex, and sleeping arrangements (mean 2.5
treated nets/household). Any untreated nets were
exchanged for treated nets. Community volunteers
promoted the correct use of treated nets by informa-
tion leaflets and home visits. The control clusters
were allowed to continue using any existing conven-
tional strategies for personal protection. They were
not provided with treated nets nor was the use of
untreated nets promoted. Individual use of nets was
monitored during quarterly house to house surveys.
For ethical reasons we did not interfere with ongoing
indoor residual spraying activities, but we collected
and considered information on spraying in the analy-
sis. Free diagnosis and treatment of visceral leishma-
niasis was provided in all clusters.
Sample size
The sample size was calculated with the method for
pair matched randomised controlled trials described
by Hayes and Bennett.17 We aimed to show a 50%
reduction in infection incidence rates in the inter-
vention group compared with control. To determine
the number of clusters required per arm we assumed
a 2% yearly L donovani infection incidence rate; 500
inhabitants per cluster with an anticipated 10% loss to
follow-up, 10% aged below 2 years, and 10% serologi-
cally positive at baseline; and a coefficient of variation
between clusters (κ) of 0.25. Under those assumptions
we anticipated a power of 90%with an α risk of 5%.The
sample size calculations determined a minimum of 10
clusters per arm. The final number of clusters was
increased to 13 per arm because the incidence of visc-
eral leishmaniasis in Nepal during the preparation
phase was lower than expected.18
Randomisation and allocation
The 26 clusters were stratified by country (16 in India
and 10 in Nepal) and population size (six and four,
respectively, having over 710 residents) and then
paired by previous average incidence rate of visceral
leishmaniasis. Clusters in each pair were randomly
allocated to group 1 or 2. The random selection of clus-
ters into groups was undertaken in Excel (Microsoft),
and the difference in the total number of cases of visc-
eral leishmaniasis reported in the past three years
between group 1 and 2 had to be less than 10%. The
intervention was then randomly allocated to one of the
groups by tossing a coin in the presence of observers.
Outcomes
The primary outcome of the clinical trial was the num-
ber of incident L donovani infections as measured by
seroconversion with the direct agglutination test at 12
and 24 months after the intervention, November-
December 2007 and 2008, respectively. Serum sam-
ples were diluted from 1:400 to 1:25 600, and the cut
off for positivity on the direct agglutination test was set
at a titre of 1:1600. This titre, which is lower than the
one used for diagnosis of visceral leishmaniasis in clini-
cally suspected cases (1:3200), was chosen to increase
the sensitivity to detect L donovani infection.16 19 The
sensitivity and specificity of the direct agglutination
test to detect visceral leishmaniasis (disease) were esti-
mated as 94.8% and 98.7%, respectively, in endemic
communities.20 Seroconversion was considered only
in individuals who had negative results on the direct
agglutination test (≤1:800) in the baseline survey (or
their first blood sample). A person was considered as
a seroconverter if the titre at one of the two subsequent
visits was ≥1:1600 and at least 2 titres above the base-
line value. A minimum of 2 titres difference was
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required to take into account the known interobserver
variability in direct agglutination test reading
(+1/−1 titre).21
All individuals aged over 2 years provided a capil-
lary blood sample collected by finger prick on aWhat-
man No 3 filter paper in November-December 2006
(baseline), 2007, and 2008. Dried filter papers were
kept at −20°C until the direct agglutination test was
performed as described elsewhere.22 A training work-
shop was organised to standardise the test protocol.
Filter papers were analysed by survey batches to mini-
mise processing errors, and 10% of the filter papers per
survey were re-tested for quality control. No systema-
tic errors were detected, and agreement between
laboratories was good.
We assessed the number of incident cases of visceral
leishmaniasis as a secondary outcome during quarterly
house to house surveys from November 2006 to May
2009. Information about any case in the family was
double checked with patients’ records. People with
fever lasting for two weeks or more were examined
by a physician and tested with a rapid diagnostic test
for visceral leishmaniasis (Kalazar Detect Rapid Test;
InBios International, Seattle, WA).23 All clinically sus-
pected cases detected during the trial were classified as
probable or certain visceral leishmaniasis by a clinician
who was blinded to the status of the cluster. Suspected
cases not corresponding to case definitions (see appen-
dix on bmj.com) or with a positive direct agglutination
test result at baseline were excluded. We excluded
from the analysis cases of visceral leishmaniasis with
onset of disease within two months after the baseline
or more than twomonths after the final survey (to take
into account the minimum incubation period)24.
Asymptomatic infections were clinically followed up
for a minimum of six months. Malaria was diagnosed
during quarterly house to house surveys with a rapid
diagnostic test (Parascreen; Zephyr Biomedicals, Goa,
India)25 in peoplewith fever. Trained fieldworkers car-
ried out verbal autopsies on all deaths recorded during
the trial. Two independent physicians ascertained
cause of death.
Statistical methods
All data were double entered into an EpiInfo 2000
database (Center for Disease Control and Prevention,
Atlanta, GA) and analysed in Stata 11 (StataCorp LP,
College Station, TX).
The datawere analysed at cluster level, and the over-
all effect of the intervention was expressed as a risk
ratio (treated nets/no treated nets) for L donovani infec-
tion. This overall estimate was obtained by taking the
geometric mean of the risk ratios for seroconversion of
each matched cluster pair. Formal tests of no inter-
vention effect and confidence intervals were obtained
with an unweighted paired t test on the log scale.26 The
confidence interval was computed on the log scale and
then back transformed to the original scale by taking
the anti-log.
Adjusted analyses were carried out in two stages.
Firstly, we used a standard individual level logistic
regressionmodel to calculateexpectednumberofevents
for each cluster ignoring the intervention. This standard
model included pair and was simultaneously adjusted
for age group, sex, indoor residual spraying, and socio-
economic status. Observed and expected values were
used to calculate residuals as the ratio of observed and
expected. The adjusted intervention effect was calcu-
lated with these residuals in a paired t test.
For secondary outcomes (such as visceral leishma-
niasis and malaria) and some subgroup analyses (such
as L donovani infection by socioeconomic status group)
where the outcomes were rare and a cluster was left
without an event, we calculated the risk ratio as the
ratio of the arithmetic mean of proportions in inter-
vention and control arms using the variance suggested
by Hayes and Moulton26 to obtain approximate 95%
confidence intervals and test probabilities, thus ignor-
ing the pairing in these situations.
For the adjusted analyses, we calculated a composite
index reflecting the socioeconomic status of each
household using principal components analysis to
aggregate wealth, housing, and demographic
characteristics.3 27 Five equally sized groups were cre-
ated for household socioeconomic status and age at
baseline. The number of times each household was
sprayed during the trial was grouped as none, once,
Allocated to control 
13 clusters (India (8), Nepal (5)) did not receive
  treated nets
Average population size: 823 participants/cluster
Range: 488-1364 participants/cluster
Total participants 10 704
Allocated to intervention 
13 clusters (India (8), Nepal (5)) received
  treated nets
Average population size: 813 participants/cluster
Range: 506-1224 participants/cluster
Total participants 10 563
Assessed for inclusion: 34 clusters (22 India, 12 Nepal)
Randomised: 26 clusters (16 India, 10 Nepal)
Follow-up 
  Clusters:
    Lost to follow-up (n=0)
    Discontinued intervention (n=0)
Participants excluded (n=723); lived <6 months
  in cluster
Follow-up 
  Clusters:
    Lost to follow-up (n=0)
    Discontinued intervention (n=0)
Participants excluded (n=734); lived <6 months
   in cluster
Analysed
Clusters:
  13 clusters (no clusters excluded)
Participants:
  Participants enrolled in trial (secondary
    outcomes) (n=9981)
Participants in serology study (primary outcome):
  Not eligible: 
    Age <2 years (n=475)
    Positive result on direct agglutination test at
      baseline (n=1077)
    Not present or did not give blood (n=644)
  Excluded as gave only one blood sample
    (n=1466)
  Total included (n=6319)
Analysed
Clusters:
  13 clusters (no clusters excluded)
Participants:
  Participants enrolled in trial (secondary
    outcomes) (n=9829)
Participants in serology study (primary outcome):
  Not eligible: 
    Age <2 years (n=484)
    Positive result on direct agglutination test at
      baseline (n=1081)
    Not present or did not give blood (n=545)
  Excluded as gave only one blood sample
    (n=1347)
  Total included (n=6372)
Did not meet inclusion criteria: 8 clusters (6 India, 2 Nepal)
Fig 1 | Trial profile of clusters and individuals allocated to use of longlasting insecticidal nets or
control
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and twice or more. Similarly, we tested whether the
intervention effect was the same in India and Nepal.
Ethical considerations
Communities were informed about the purpose of the
trial and consent for inclusion was sought from village
leaders. Written informed consent was obtained from
head of households and from each individual or their
guardian for those aged under 18. For ethical reasons,
we conducted an interim analysis 12 months after the
intervention, with a pre-planned rule to stop the trial
and distribute treated nets in the control clusters if the
95%confidence interval indicateda30%orgreater reduc-
tion in the incidence rate of visceral leishmaniasis in the
intervention group compared with the control group.
RESULTS
Participants flow
Out of 15 504 eligible seronegative people, we
included 12 691 (82%) in the analysis of the main out-
come (infection) and considered 19 810 of the 21 267
(93%) initially enrolled for the secondary (disease) end
point. Figure 1 shows reasons for exclusion and the
range and number of households and people per clus-
ter and allocation group. The proportion of people lost
to follow-up (not present or with one or no blood sam-
ple) was slightly higher in the control group (21%, (644
+1466)/9981) than in the intervention group (19%,
(545+1347)/9829). But the characteristics of the parti-
cipants lost to follow-up in both groups were similar
(mean age 22 v 23, males 62% v 63%, mean socioeco-
nomic status 2.0 v 2.2, in intervention and control
groups respectively). Intervention and control groups
were well balanced at individual and cluster levels, but
the prevalence of positive results on the direct aggluti-
nation test at baseline in India was almost twice as high
as in Nepal, despite the previous annual incidence of
visceral leishmaniasis being similar (table 1). Partici-
pants in the group in which the infection end point was
measured—that is, thosewith negative results on direct
agglutination test at baseline—were slightly older and
more were female than the general population, but,
again, this was well balanced between study groups
(table 2). Vector densities at baselinewere comparable
in intervention and control clusters. 11 During the two
year follow-up, 14 clusters (six intervention and eight
control) were sprayed under the national control pro-
gramme with limited or no effect on vector density. 11
In intervention clusters, 8920/9829 (91%) of the indi-
viduals slept regularly (that is, over 80% of the nights)
under a treated net. Those observations were con-
firmed by an additional acceptability survey
(V Vanlerberghe, personal communication, January
2010). The use of untreated nets in the control group
was variable; 7012/9981 (70%) used a bed net at least
once during the trial but only 2978/9981 (30%) used it
regularly throughout the year as most of the house-
holds did not have enough nets for all their members.
Outcomes and estimation
Primary outcome
The number of individuals who seroconverted ranged
from 5 to 60 per cluster, and the incidence of infection
was variable among cluster pairs (fig 2). The risk of
seroconversion during the two year follow-up was sig-
nificantly different between countries: 7.2% in India
(529/7368) and 3.1% (163/5323) in Nepal. The overall
risk of seroconversion in the intervention (5.4%, 347/
6372) and control (5.5%, 345/6319) groups was simi-
lar. At cluster level, the risk of infectionwas reduced by
10% in the intervention clusters comparedwith control
clusters, but this effect was not significant (risk ratio
0.90, 95% confidence interval 0.49 to 1.65). The results
were similar in the model adjusted for age, sex, indoor
residual spraying, and socioeconomic status (0.89, 0.48
to 1.64) (table 3). Longlasting insecticidal nets seemed
to have an opposite effect on seroconversion according
Table 1 | Baseline (November-December 2006) demographic information in intervention
(longlasting insecticidal nets) and control groups for total study population. Figures are
percentages (numbers) unless stated otherwise
Variable Intervention Control
Total
No of participants 9829 (13 clusters) 9981 (13 clusters)
Mean (SD) age (years) 22.7 (19.2) 23.0 (19.2)
No (%) male 4858 (49.4) 4916 (49.2)
Annual incidence of visceral leishmaniasis 2003-5 1.4 (418/9260) 1.5 (410/8722)
Positive direct agglutination test results at baseline 14.9 (1039/6975) 14.5 (940/6473)
No (range) of households/cluster 1690 (78 to 240) 1803 (88 to 224)
Mean (SD) No of members in household 5.8 (2.7) 5.5 (2.5)
Clusters sprayed before intervention* 6 6
Households with untreated nets (95% CI)† 76.2 (67.2 to 85.1) 78.1 (69.3 to 87.0)
Mean indicator of socioeconomic status‡ (SD) 1.9 (1.4) 2.1 (1.4)
India
No of participants 5987 (8 clusters) 6207 (8 clusters)
Mean (SD) age (years) 21.9 (19.7) 22.4 (19.6)
No (%) male 2980 (49.8) 3067 (49.4)
Annual incidence of visceral leishmaniasis 2003-5¶ 1.51 (279/5677) 1.40 (261/5640)
Positive direct agglutination test results at baseline 19.4 (785/4059) 17.7 (705/3992)
No (range) of households/cluster 967 (78 to 172) 1082 (88 to 224)
Mean (SD) No of members in household 6.2 (3.0) 5.7 (2.7)
Clusters sprayed before intervention* 1 3
Households with untreated nets (95% CI)† 81.4 (70.5 to 92.3) 81.5 (67.0 to 95.9)
Mean indicator of socioeconomic status‡ (SD) 2.0 (1.4) 2.0 (1.5)
Nepal
No of participants 3842 (5 clusters) 3774 (5 clusters)
Mean (SD) age (years) 23.9 (18.6) 23.9 (18.3)
No (%) male 1878 (48.9) 1849 (49.0)
Annual incidence of visceral leishmaniasis 2003-5 1.3 (139/3583) 1.6 (149/3082)
Positive direct agglutination test results at baseline 8.7 (254/2916) 9.5 (235/2481)
No (range) of households/cluster 723 (103 to 240) 721 (103 to 196)
Mean (SD) No of members in household 5.3 (2.2) 5.2 (2.3)
Clusters sprayed before intervention* 5 3
Households with untreated nets (95% CI)† 67.8 (49.6 to 86.0) 72.8 (62.7 to 82.9)
Mean indicator of socioeconomic status‡ (SD) 1.9 (1.4) 2.1 (1.4)
*July 2005 to November 2006.
†At least one untreated net observed by study teams. Percentage estimated from survey in 25 households per
cluster conducted in August-September 2006.13
‡Composite index calculated for each household with principal components analysis to aggregate wealth,
housing, and demographic characteristics.27 Household indexes categorised in five equally sized groups.
¶Incidence in nine clusters (four in intervention) calculated from 3.5 years.
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to the direct agglutination test result in India (1.09, 0.58
to 2.04) and Nepal (0.66, 0.12 to 3.56), but the inter-
actionwas not significant (P=0.40). Similar resultswere
obtained in the adjustedmodel: risk ratio 1.09 and 0.57
in India and Nepal, respectively (table 3).
Secondary outcomes
A total of 168 suspected cases of visceral leishmaniasis
(129 in India and 39 in Nepal) were identified during
the trial. The case ascertainment procedure reduced
this number to 77 confirmed cases; 62 in India and 15
inNepal (fig 3). The overall risk of visceral leishmania-
sis during the two year follow-up was 0.38% (37/9829)
and 0.40% (40/9981) in the intervention group and
control group, respectively. The cluster level analysis
showed that longlasting insecticidal nets reduced the
risk of visceral leishmaniasis by 1% (risk ratio 0.99,
95% confidence interval 0.46 to 1.40), but the effect
was not significant. The country specific and adjusted
results were similar and not significant (table 3). We
obtained analogous results when we analysed all sus-
pected cases andwhen we used a sixmonth incubation
period (see appendix on bmj.com).
A total of 225 cases of malaria were identified,
mostly in India (n=220) and mostly non-P falciparum
malaria (n=208); there were 12 cases of P falciparum
malaria and five undefined species. There was a non-
significant reduction in cases ofmalaria in intervention
clusters (risk ratio 0.63, 0.29 to 1.36), but the adjusted
effect was stronger and significant (0.46, 0.28 to 0.77).
In India, where most malaria cases were reported, the
risk ratio was 0.60 (0.38 to 0.94) in the adjusted model
(table 3). Similarly, the total number of deaths was
reduced in intervention clusters (0.75, 0.50 to 1.13),
but the effect was not significant (table 3). None of
the deaths during the trial was attributable to visceral
leishmaniasis.
DISCUSSION
In this large scale randomised controlled trial of the
effectiveness of longlasting insecticidal nets in
preventing visceral leishmaniasis, we found the risk
for L donovani infection was reduced by 10% in inter-
vention clusters. This was a small and non-significant
effect, though its wide confidence interval does not rule
out a potential beneficial effect. The findings in the pri-
mary (serological) and secondary (clinical visceral
leishmaniasis) end points were consistent as there was
no difference in the incidence of visceral leishmaniasis
between intervention and control clusters. Use of the
treated nets in intervention clusters was high in all sea-
sons and significantly reduced the risk ofmalaria, espe-
cially in India, where 98% of all malaria cases in this
trial were reported.
Strengths and limitations
The incidence of Leishmania infection in study clusters
could have been lowered by the active detection and
treatment of cases of visceral leishmaniasis implemen-
ted during the trial but did not fall below the assump-
tion of 2% annual incidence made when we calculated
the sample size. If we assume a constant intervention
effect over all pairs, the observed coefficient of varia-
tion forL donovani infectionwas 0.56. This value can be
of use for the planning of future intervention trials.
While our sample size calculation was based on a
lower κ than the one finally observed, the power of
the study was increased by adding six extra clusters.
The impact of migration on the estimation of effect
was limited as the number of individuals excluded
was similar in both groups. Follow-up rates during
the trial were high, with 82% and 93% for the primary
and secondary outcome, respectively. The proportion
lost to follow-up was slightly higher in control (21%)
than in intervention (19%) clusters, but we do not
expect this to affect the estimations as the characteris-
tics of these people were similar. We used a cluster
level model to analyse the trial data as this was the ana-
lytical model specified for the sample size formula17
and is the method recommended by Hayes and
Moulton26 for pair matched trials with fewer than 15
clusters per arm. The trial results were not significantly
modified when we used a multi-level model (random
effects logistic regression) (see appendix on bmj.com).
Table 2 | Baseline demographic information in intervention
(longlasting insecticidal nets) and control groups for eligible
subgroups observed for main outcome (seroconversion on
direct agglutination test)
Variable Intervention Control
Total
No of participants 6372 (13 clusters) 6319 (13 clusters)
Mean (SD) age (years) 23.6 (19.1) 23.3 (19.0)
No (%) male 2882 (45.2) 2809 (44.5)
India
No of participants 3568 (8 clusters) 3800 (8 clusters)
Mean (SD) age (years) 22.9 (19.8) 22.4 (19.3)
No (%) male 1570 (44.0) 1669 (43.9)
Nepal
No of participants 2804 (5 clusters) 2519 (5 clusters)
Mean (SD) age (years) 24.5 (18.3) 24.7 (18.4)
No (%) male 1312 (46.8) 1140 (45.3)
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Fig 2 | Observed proportion of seroconversions according to
result of direct agglutination test by cluster and pair with 95%
confidence intervals
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We used the direct agglutination test as a marker for
infection, as in previous epidemiological
studies,16 19 28-30 because the low incidence of visceral
leishmaniasis precluded its use as primary outcome.
We found no published estimates on the sensitivity
and specificity of the direct agglutination test to test
for infection in humans, but we have shown that recent
seroconverters are at a substantially higher risk of
developing visceral leishmaniasis in this setting.31 The
trial outcome was not modified when less (that is, ser-
oconversion based on a 1 titre difference) ormore (that
is, higher direct agglutination test cut offs) specific cri-
teria were used (see appendix on bmj.com). Though
others have used the leishmanin skin test as a marker
of exposure, we could not do so in our trial because of
unsatisfactory performance in India.32
Interpretation
As adherence to use of the treated nets was high during
the trial, the lack of effect could be explained by biolo-
gical factors. World Health Organization pesticide
evaluation scheme (WHOPES) standard susceptibility
tests showed that P argentipes is susceptible to deltame-
thrin in the study clusters.33 Moreover, indoor density
of P argentipeswas reduced by 25% in the study clusters
that used treated nets comparedwith control clusters.11
This reduction, however, might be insufficient to have
an impact on immunological and clinical outcomes if,
in contrast with previous data,5 transmission of L dono-
vani occurs partly outside the house, as suggested by
recent studies.9 34 35 This trial measured the effective-
ness of distribution of treated nets in a real life context,
where some clusters were sprayed and some people in
control clusters used untreated nets. The use of
untreated nets before the trial did not prevent all trans-
mission in these communities. Analysis showed that
protection provided by untreated nets was similar to
that from treated nets; whereas both treated and
untreated nets seemed to provide some degree of pro-
tection compared with not using nets (adjustedmodels
P<0.06 and P<0.09, respectively) (see appendix on
bmj.com). This is supported by entomological data
from the study clusters.36
The fact that 14 of the 26 study clusters were sprayed
as part of the visceral leishmaniasis national control
programmes during the trial had a limited impact on
vector density, as reported elsewhere.11 Moreover, the
effect of treated nets on L donovani infection was not
significantly modified in the adjusted models, which
included indoor residual spraying as a variable.
Under controlled conditions, indoor residual spraying
effectively reduces the indoor density of P argentipes.10
When applied as part of the national vector control
programmes, however, indoor residual spraying was
Table 3 | Effect of longlasting insecticidal nets on L donovani infection measured by direct agglutination test with cut off
1:1600 and minimum of two titres difference and secondary outcomes: visceral leishmaniasis, malaria cases and all causes
of death. Overall and country specific unadjusted and adjusted risk ratios for intervention compared with control from
cluster analysis
Variable Intervention Control
Risk ratio (95% CI), P value*
Unadjusted Adjusted†
Overall
No in serology study 6372 (13 clusters) 6319 (13 clusters) — —
No of seroconversions (%) 347 (5.4) 345 (5.5) 0.90 (0.49 to 1.65), 0.71 0.89 (0.48 to 1.64), 0.68
Total No of participants 9829 (13 clusters) 9981 (13 clusters) — —
Visceral leishmaniasis (%)‡ 37 (0.38) 40 (0.40) 0.99 (0.46 to 2.16), 0.99 1.15 (0.61 to 2.16), 0.64
Malaria (%)‡ 88 (0.90) 137 (1.37) 0.63 (0.29 to 1.36), 0.21 0.46 (0.28 to 0.77), 0.01
All causes of death (%) 124 (1.26) 167 (1.67) 0.75 (0.50 to 1.13), 0.15 0.78 (0.56 to 1.10), 0.15
India
No in serology study 3568 (8 clusters) 3800 (8 clusters) — —
No of seroconversions (%) 276 (7.7) 253 (6.7) 1.09 (0.58 to 2.04), 0.76 1.09 (0.58 to 2.05), 0.75
Total No of participants 5988 (8 clusters) 6207 (8 clusters) — —
Visceral leishmaniasis (%)‡ 31 (0.52) 31 (0.50) 1.00 (0.41 to 2.44), 1.00 0.94 (0.44 to 2.02), 0.85
Malaria (%)‡ 87 (1.45) 133 (2.14) 0.64 (0.36 to 1.13), 0.11 0.60 (0.38 to 0.94), 0.03
All causes of death (%) 80 (1.34) 121 (1.95) 0.62 (0.32 to 1.19), 0.13 0.72 (0.44 to 1.19), 0.17
Nepal
No in serology study 2804 (5 clusters) 2519 (5 clusters) — —
No of seroconversions (%) 71 (2.5) 92 (3.6) 0.66 (0.12 to 3.56), 0.53 0.57 (0.11 to 2.97), 0.40
Total No of participants 3842 (5 clusters) 3774 (5 clusters) — —
Visceral leishmaniasis (%)‡ 6 (0.16) 9 (0.24) 0.96 (0.13 to 7.39), 0.96 1.55 (0.17 to 14.18), 0.57
Malaria (%)‡ 1 (0.03) 4 (0.11) 0.18 (0.00 to 14.38), 0.23 —§
All causes of death (%) 44 (1.15) 46 (1.22) 1.02 (0.67 to 1.55), 0.93 1.06 (0.69 to 1.64), 0.73
*Test for no intervention effect.
†Adjusted for age group, sex, times sprayed, and socioeconomic status.
‡Rare outcomes: some clusters did not record any event during study period. Risk ratio calculated as ratio of arithmetic mean of proportions in
intervention and control arm with variance (see appendix on bmj.com).
§Too few cases of malaria to adjust for covariates.
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shown to have a limited effect or no effect on indoor
density of P argentipes in villages in Bihar with endemic
visceral leishmaniasis9 and,more generally, on control
of visceral leishmaniasis.6 The poor quality of routine
indoor residual spraying operations for visceral leish-
maniasis in the region is the main reason for this
failure37 and has contributed to the development of
DDT resistance in districts with endemic visceral
leishmaniasis6 and in our study areas in particular.33
Similarly, the variability in incidence observed in
some study clusters—notably, pairs G and L (see
fig 2)—does not seem to be explained by the effect of
indoor residual spraying as both clusters in pairGwere
sprayed once and neither cluster was sprayed in pair L.
The differences could be better explained by heteroge-
neity in the transmission dynamics (because of, for
example, heterogeneity in population susceptibility
and vector infectivity). This variability does not seem
to affect the trial outcomes, as the effect of treated nets
on L donovani infection was not significantly altered
when we repeated the analyses excluding the clusters
with exceptionally high rates (outliers) (see appendix
on bmj.com).
Our results are in contrast with those of an observa-
tional study in Sudan, which reported a 27% reduction
in cases with a smaller mesh size.12 The mesh size used
in this trial (2 mm) would not be a perfect physical bar-
rier for sandflies, but the insecticide coating of the
fibres should prevent their passage.38
Implications
Our results show that the distribution of longlasting
insecticidal nets did not confer additional protection
against L donovani infection and visceral leishmaniasis
in the current context in endemic communities in India
and Nepal when compared with existing control prac-
tices (that is, irregular indoor residual spraying, use of
untreated nets, and treatment of visceral leishmania-
sis). Also distribution of treated nets did not reduce
the annual incidence of visceral leishmaniasis below
18.8 per 10 000, which by far exceeds the elimination
target in the region.7 The most biologically plausible
explanation for our results is that a substantial fraction
of L donovani transmission occurs outside the house,
where any nets would have less impact on preventing
sandfly-human contact. Nonetheless, insecticide trea-
ted nets should not be dismissed as a potential inter-
vention for visceral leishmaniasis prevention on the
Indian subcontinent, as more research on vector beha-
viour and implementation of such nets is warranted.
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Fig 3 | Case ascertainment for visceral leishmaniasis and reasons for exclusion
WHAT IS ALREADY KNOWN ON THIS TOPIC
Longlasting insecticidal nets are among the major breakthroughs in the control of malaria in
recent years, and expectations were raised about their potential to prevent other vector-
borne diseases
Observational evidence in East Africa and Asia suggested that people sleeping under nets
were protected against visceral leishmaniasis
WHAT THIS STUDY ADDS
Village-wide distribution of insecticide treated nets in India and Nepal did not confer
protection against Leishmania donovani infection or visceral leishmaniasis when compared
with existing preventive practice (irregular insecticide residual spraying and use of untreated
nets)
RESEARCH
BMJ | ONLINE FIRST | bmj.com page 7 of 8
London School of Hygiene and Tropical Medicine, and the University of
Antwerp.
Data sharing: Technical appendix, statistical code, and dataset available
from the corresponding author at mboelaert@itg.be. Participants’
consent for data sharing was not obtained but the presented data are
anonymised and risk of identification is low.
1 Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, Sachs JD,
et al. Control of neglected tropical diseases. N Engl J Med
2007;357:1018-27.
2 Desjeux P. Leishmaniasis: current situation and new perspectives.
Comp Immunol Microbiol Infect Dis 2004;27:305-18.
3 Boelaert M, Meheus F, Sanchez A, Singh SP, Vanlerberghe V,
Picado A, et al. The poorest of the poor: a poverty appraisal of
households affected by visceral leishmaniasis in Bihar, India. Trop
Med Int Health 2009;14:639-44.
4 Swaminath CS, Shortt HE, Anderson LA. Transmission of Indian kala-
azar to man by the bites of Phlebotomus argentipes, ann and brun.
1942. Indian J Med Res 2006;123:473-7.
5 Dinesh DS, Ranjan A, Palit A, Kishore K, Kar SK. Seasonal and
nocturnal landing/biting behaviour of Phlebotomus argentipes
(Diptera: Psychodidae). Ann Trop Med Parasitol 2001;95:197-202.
6 OstynB, VanlerbergheV, PicadoA, DineshDS, Sundar S, Chappuis F,
et al. Vector control by insecticide-treated nets in the fight against
visceral leishmaniasis in the Indian subcontinent, what is the
evidence? Trop Med Int Health 2008;13:1073-85.
7 Bhattacharya SK, Sur D, Sinha PK, Karbwang J. Elimination of
leishmaniasis (kala-azar) from the Indian subcontinent is technically
feasible and operationally achievable. Indian J Med Res
2006;123:195-6.
8 Lengeler C. Insecticide-treated bed nets and curtains for preventing
malaria. Cochrane Database Syst Rev 2004;2:CD000363.
9 Dinesh DS, Das P, Picado A, Davies C, Speybroeck N, Ostyn B, et al.
Long-lasting insecticidal nets fail at household level to reduce
abundance of sandfly vector Phlebotomus argentipes in treated
houses in Bihar (India). Trop Med Int Health 2008;13:953-8.
10 Joshi AB, Das ML, Akhter S, Chowdhury R, Mondal D, Kumar V, et al.
Chemical and environmental vector control as a contribution to the
elimination of visceral leishmaniasis on the Indian subcontinent:
cluster randomized controlled trials in Bangladesh, India and Nepal.
BMCMed 2009;7:54.
11 Picado A, DasML, Kumar V, Kesari S, Dinesh DS, Roy L, et al. Effect of
village-wide use of long-lasting insecticidal nets on visceral
leishmaniasis vectors in India and Nepal: a cluster randomized trial.
PLoS Negl Trop Dis 2010;4:e587.
12 Ritmeijer K, Davies C, van Zorge R, Wang SJ, Schorscher J, Dongu’du
SI, et al. Evaluation of a mass distribution programme for fine-mesh
impregnated bednets against visceral leishmaniasis in eastern
Sudan. Trop Med Int Health 2007;12:404-14.
13 Vanlerberghe V, Singh SP, Paudel IS, Ostyn B, Picado A, Sanchez A,
et al. Determinants of bednet ownership and use in visceral
leishmaniasis-endemic areas of the Indian subcontinent. Trop Med
Int Health 2010;15:60-7.
14 Bern C, Hightower AW, Chowdhury R, Ali M, Amann J, Wagatsuma Y,
et al. Risk factors for kala-azar in Bangladesh. Emerg Infect Dis
2005;11:655-62.
15 Bern C, Joshi AB, Jha SN, Das ML, Hightower A, Thakur GD, et al.
Factors associated with visceral leishmaniasis in Nepal: bed-net use
is strongly protective. Am J Trop Med Hyg 2000;63:184-8.
16 Saha S, Ramachandran R, Hutin YJF, Gupte MD. Visceral
leishmaniasis is preventable in a highly endemic village in West
Bengal, India. Trans R Soc Trop Med Hyg 2009;103:737-42.
17 Hayes RJ, Bennett S. Simple sample size calculation for cluster-
randomized trials. Int J Epidemiol 1999;28:319-26.
18 Rijal S, Uranw S, Chappuis F, Picado A, Khanal B, Paudel IS, et al.
Epidemiology of Leishmania donovani infection in high-transmission
foci in Nepal. Trop Med Int Health 2010;15:21-8.
19 Davies CR, Mazloumi Gavgani AS. Age, acquired immunity and the
risk of visceral leishmaniasis: a prospective study in Iran.
Parasitology 1999;119:247-57.
20 Chappuis F, Rijal S, Soto A, Menten J, Boelaert M. A meta-analysis of
the diagnostic performance of the direct agglutination test and rK39
dipstick for visceral leishmaniasis. BMJ 2006;333:723.
21 Boelaert M, El Safi S, Mousa H, Githure J, Mbati P, Gurubacharya V,
et al. Multi-centre evaluation of repeatability and reproducibility of
the direct agglutination test for visceral leishmaniasis. Trop Med Int
Health 1999;4:31-7.
22 Jacquet D, Boelaert M, Seaman J, Rijal S, Sundar S, Menten J, et al.
Comparative evaluation of freeze-dried and liquid antigens in the
direct agglutination test for serodiagnosis of visceral leishmaniasis
(ITMA-DAT/VL). Trop Med Int Health 2006;11:1777-84.
23 Sundar S,Maurya R, SinghRK, Bharti K, Chakravarty J, Parekh A, et al.
Rapid, noninvasive diagnosis of visceral leishmaniasis in India:
comparison of two immunochromatographic strip tests for detection
of anti-K39 antibody. J Clin Microbiol 2006;44:251-3.
24 Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, Peeling RW, et al.
Visceral leishmaniasis: what are the needs for diagnosis, treatment
and control? Nat Rev Microbiol 2007;5:873-82.
25 World Health Organization. Malaria rapid diagnostic test
performance—results ofWHOproduct testingofmalaria RDTs: round
1 (2008). TDR/WHO, 2009.
26 Hayes RJ, Moulton LH. Cluster randomised trials. Chapman andHall/
CRC, 2009.
27 Singh SP, Picado A, Boelaert M, Gidwani K, Andersen EW, Ostyn B,
et al. The epidemiology of Leishmania donovani infection in high
transmission foci in India. Trop Med Int Health 2010;15:12-20.
28 Chowdhury MS, el Harith A, al Massum A, al Karim E, al Rahman A.
Prevalence of agglutinating anti-Leishmania antibodies in twomulti-
thousand Bengoli communities. Parasitol Res 1993;79:444-50.
29 Koirala S, Karki P, DasML, Parija SC, Karki BM. Epidemiological study
of kala-azar by direct agglutination test in two rural communities of
eastern Nepal. Trop Med Int Health 2004;9:533-7.
30 Schenkel K, Rijal S, Koirala S, Koirala S, Vanlerberghe V, Van der
Stuyft P, et al. Visceral leishmaniasis in southeastern Nepal: a cross-
sectional survey on Leishmania donovani infection and its risk
factors. Trop Med Int Health 2006;11:1792-9.
31 Ostyn B, Gidwani K, Picado A, Chappuis F, Khanal B, Singh S, et al.
Incidence of asymptomatic infection with L donovani and their
evolution in high endemic villages in India and Nepal. Trop Med Int
Health 2009;14:60-1.
32 Gidwani K, Rai M, Chakravarty J, Boelaert M, Sundar S. Evaluation of
leishmanin skin test in Indian visceral leishmaniasis. Am J Trop Med
Hyg 2009;80:566-7.
33 Dinesh D, Das M, Picado A, Roy L, Rijal S, Singh SP, et al. Insecticide
susceptibility of Phlebotomus argentipes in visceral leishmaniasis
endemic districts in India and Nepal. PLoS Negl Trop Dis
2010;4:e859.
34 Dinesh DS, Bhattacharya SK, Das P. Peridomestic breeding and
resting sites of sandflies (Diptera: Psychodidae) in Bihar, India.
Entomol News 2010;120:496-501.
35 Singh R, Lal S, SaxenaVK. Breeding ecology of visceral leishmaniasis
vector sandfly in Bihar state of India. Acta Trop 2008;107:117-20.
36 Picado A, Kumar V, DasM, Burniston I, Roy L, SumanR, et al. Effect of
untreated bed nets on blood-fed Phlebotomus argentipes in kala-
azar endemic foci in Nepal and India.Mem Inst Oswaldo Cruz
2009;104:1183-6.
37 Chowdhury R, HudaMM, Kumar V, Das P, Joshi AB, Banjara MJ, et al.
The Indian andNepalese programmes of indoor residual spraying for
the elimination of visceral leishmaniasis: performance and
effectiveness Ann Trop Med Hyg Parasitol (in press).
38 Courtenay O, Gillingwater K, Gomes PA, Garcez LM, Davies CR.
Deltamethrin-impregnated bednets reduce human landing rates of
sandfly vector Lutzomyia longipalpis in Amazon households.Med
Vet Entomol 2007;21:168-76.
Accepted: 8 October 2010
RESEARCH
page 8 of 8 BMJ | ONLINE FIRST | bmj.com
